CardiaTec
PrivateLast Round
Seed
Sep 10, 2024
Total Funding Raised
$8.17M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CardiaTec operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Seed round in September 2024.
CardiaTec is a biotechnology company that leverages artificial intelligence and large-scale multi-omics data to discover novel drug targets for cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CardiaTec Comparables
Compare CardiaTec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vasa Therapeutics | 83% | |
| Dynomics | 82% | |
| G3 Therapeutics | 80% |
For institutional investors. Book with your work email.
CardiaTec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 10, 2024 | ||||
| Pre Seed | Jul 6, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CardiaTec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Montage Ventures | Seed |
| o2h ventures | Pre Seed |
| APEX Ventures | Seed, Pre Seed |
| Cambridge Enterprise | Pre Seed |
| Crista Galli Ventures | Pre Seed |
| Continuum Health Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 917% MoM, reaching 1K.
- Jun 19, 2026
Monthly visitors grew 443% MoM, reaching 2.3K.
For institutional investors. Book with your work email.
CardiaTec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CardiaTec's valuation, stock price, and market status.
Is CardiaTec a public or private company?
CardiaTec is a private company.
What is the current stock price of CardiaTec?
CardiaTec is a private company, so its shares have no public market price. Caplight tracks CardiaTec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CardiaTec worth (valuation)?
Valuation information for CardiaTec is not publicly available.
Can I buy CardiaTec stock?
CardiaTec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CardiaTec's last funding round?
CardiaTec's most recent funding round was Seed on September 10, 2024.
Who are the main investors in CardiaTec?
Key investors in CardiaTec include Montage Ventures, APEX Ventures.
Will CardiaTec IPO soon?
No public IPO plans have been announced for CardiaTec.
How can I track CardiaTec secondary market activity?
Caplight tracks bids, offers, and trades in CardiaTec's shares on secondary markets.